Literature DB >> 12760262

Changes in serum cytokine concentration: a morphological study of liver cirrhosis induced by common bile duct ligation in rats.

Byung Seok Lee1, Nam Jae Kim, Hyun Yong Jeong, Heon Young Lee, Dae Young Kang, Seung Moo Noh.   

Abstract

BACKGROUND: Liver cirrhosis is a diffuse hepatic fibrosis, and nodule formation. The transforming growth factor-beta 1 (TGF-beta 1) and interleukin-10 (IL-10) are very important cytokines in hepatic fibrogenesis. The aim of this study was to examine the relationship between the changes of the serum cytokines and morphological changes following common bile duct ligation in experimental rats.
METHODS: Common bile ducts of fifty male Sprague-Dawley rats were ligated and seven male rats were set aside as controls. Five rats each were sacrificed in 1, 2, 4, 6, 8, and 10 experimental weeks. Light microscopic studies and liver function tests were performed during the above experimental weeks. The levels of serum TGF-beta 1 and IL-10 were analyzed by ELISA. Also, alpha smooth muscle actin (alpha-SMA) immunohistochemical stains were performed.
RESULTS: On the eighth week after common bile duct ligation, most hepatic lobular areas had been replaced by proliferated bile ducts and fibrous tissue (typical biliary cirrhosis). Serum TGF-beta 1 levels between the control group and the common bile duct ligation group showed statistically significant changes. The alpha-SMA was stained at proliferated bile ducts. These findings were correlated with each other.
CONCLUSION: Thus, this experiment may clarify our understanding of the mechanism in liver fibrogenesis. Also, indicated is a need to explore the therapeutic potential of these cytokines as anti-fibrotic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12760262      PMCID: PMC4531599          DOI: 10.3904/kjim.2003.18.1.6

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  19 in total

1.  Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation.

Authors:  Y Matsumura; I Sakaida; K Uchida; T Kimura; T Ishihara; K Okita
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

Review 2.  Molecular regulation of hepatic fibrogenesis.

Authors:  E Olaso; S L Friedman
Journal:  J Hepatol       Date:  1998-11       Impact factor: 25.083

Review 3.  Is interleukin-10 antifibrogenic in chronic liver injury?

Authors:  H Tsukamoto
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

Review 4.  Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte.

Authors:  M Pinzani
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

Review 5.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver.

Authors:  H Nakatsukasa; R P Evarts; C C Hsia; S S Thorgeirsson
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

7.  Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis.

Authors:  K Thompson; J Maltby; J Fallowfield; M McAulay; H Millward-Sadler; N Sheron
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

8.  Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice.

Authors:  H Louis; J L Van Laethem; W Wu; E Quertinmont; C Degraef; K Van den Berg; A Demols; M Goldman; O Le Moine; A Geerts; J Devière
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

9.  Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery.

Authors:  M K Kennedy; D S Torrance; K S Picha; K M Mohler
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

10.  Transforming growth factor-beta: biological function and chemical structure.

Authors:  M B Sporn; A B Roberts; L M Wakefield; R K Assoian
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

View more
  4 in total

1.  Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10.

Authors:  Mei-Na Shi; Yue-Hong Huang; Wei-Da Zheng; Li-Juan Zhang; Zhi-Xin Chen; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

2.  Inhibitory effects of rapamycin on the different stages of hepatic fibrosis.

Authors:  Yun Jeung Kim; Eaum Seok Lee; Seok Hyun Kim; Heon Young Lee; Seung Moo Noh; Dae Young Kang; Byung Seok Lee
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms.

Authors:  Khanh Vinh Quốc L Ng; Lan Thi Hoàng Nguyễn
Journal:  Gastroenterol Res Pract       Date:  2013-03-26       Impact factor: 2.260

4.  Cholestasis-induced adaptive remodeling of interlobular bile ducts.

Authors:  Nachiket Vartak; Amruta Damle-Vartak; Beate Richter; Olaf Dirsch; Uta Dahmen; Seddik Hammad; Jan G Hengstler
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.